STAAR Surgical Company
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $44.03
- Today's High:
- $45.58
- Open Price:
- $44.37
- 52W Low:
- $40.95
- 52W High:
- $96.43
- Prev. Close:
- $44.61
- Volume:
- 813091
Company Statistics
- Market Cap.:
- $2.16 billion
- Book Value:
- 7.294
- Revenue TTM:
- $305.92 million
- Operating Margin TTM:
- 8.58%
- Gross Profit TTM:
- $223.38 million
- Profit Margin:
- 8.14%
- Return on Assets TTM:
- 4.02%
- Return on Equity TTM:
- 7.62%
Company Profile
STAAR Surgical Company had its IPO on 1983-07-15 under the ticker symbol STAA.
The company operates in the Healthcare sector and Medical Instruments & Supplies industry. STAAR Surgical Company has a staff strength of 882 employees.
Stock update
Shares of STAAR Surgical Company opened at $44.37 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $44.03 - $45.58, and closed at $44.9.
This is a +0.65% increase from the previous day's closing price.
A total volume of 813,091 shares were traded at the close of the day’s session.
In the last one week, shares of STAAR Surgical Company have increased by +4.27%.
STAAR Surgical Company's Key Ratios
STAAR Surgical Company has a market cap of $2.16 billion, indicating a price to book ratio of 8.8181 and a price to sales ratio of 9.75.
In the last 12-months STAAR Surgical Company’s revenue was $305.92 million with a gross profit of $223.38 million and an EBITDA of $31.34 million. The EBITDA ratio measures STAAR Surgical Company's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, STAAR Surgical Company’s operating margin was 8.58% while its return on assets stood at 4.02% with a return of equity of 7.62%.
In Q2.3333333333333, STAAR Surgical Company’s quarterly earnings growth was a negative -53.8% while revenue growth was a positive 13.8%.
STAAR Surgical Company’s PE and PEG Ratio
- Forward PE
- 48.5437
- Trailing PE
- 85.7885
- PEG
- -4.89
Its diluted EPS in the last 12-months stands at $0.52 per share while it has a forward price to earnings multiple of 48.5437 and a PEG multiple of -4.89. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into STAAR Surgical Company’s profitability.
STAAR Surgical Company stock is trading at a EV to sales ratio of 9.4561 and a EV to EBITDA ratio of 48.6572. Its price to sales ratio in the trailing 12-months stood at 9.75.
STAAR Surgical Company stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $440.65 million
- Total Liabilities
- $54.19 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $3.01 million
- Dividend Payout Ratio
- 0%
STAAR Surgical Company ended 2024 with $440.65 million in total assets and $0 in total liabilities. Its intangible assets were valued at $440.65 million while shareholder equity stood at $353.70 million.
STAAR Surgical Company ended 2024 with $0 in deferred long-term liabilities, $54.19 million in other current liabilities, 485000.00 in common stock, $-63861000.00 in retained earnings and $1.79 million in goodwill. Its cash balance stood at $94.70 million and cash and short-term investments were $192.01 million. The company’s total short-term debt was $4,175,000 while long-term debt stood at $0.
STAAR Surgical Company’s total current assets stands at $328.00 million while long-term investments were $0 and short-term investments were $97.31 million. Its net receivables were $94.44 million compared to accounts payable of $11.44 million and inventory worth $25.48 million.
In 2024, STAAR Surgical Company's operating cash flow was $0 while its capital expenditure stood at $3.01 million.
Comparatively, STAAR Surgical Company paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $44.9
- 52-Week High
- $96.43
- 52-Week Low
- $40.95
- Analyst Target Price
- $57.11
STAAR Surgical Company stock is currently trading at $44.9 per share. It touched a 52-week high of $96.43 and a 52-week low of $96.43. Analysts tracking the stock have a 12-month average target price of $57.11.
Its 50-day moving average was $48.31 and 200-day moving average was $58.44 The short ratio stood at 7.9 indicating a short percent outstanding of 0%.
Around 66.6% of the company’s stock are held by insiders while 10247.3% are held by institutions.
Frequently Asked Questions About STAAR Surgical Company
Similar Industry Stocks (Medical Instruments & Supplies)
Most Active
Top Gainers
Top Losers
About
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.